Long-term data on the survival of patients with prostate cancer treated with radical prostatectomy in the prostate-specific antigen era
✍ Scribed by Hendrik Isbarn; Manuela Wanner; Georg Salomon; Thomas Steuber; Thorsten Schlomm; Jens Köllermann; Guido Sauter; Alexander Haese; Hans Heinzer; Hartwig Huland; Markus Graefen
- Book ID
- 109056380
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 365 KB
- Volume
- 106
- Category
- Article
- ISSN
- 1464-4096
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND The objectives of the current study were to determine the long‐term biochemical recurrence (BCR) and cancer‐specific survival (CSS) rates for men with seminal vesicle invasion (SVI) and to identify risk factors for freedom from BCR and CSS in patients who received treatme
## Abstract ## BACKGROUND To the authors' knowledge, consensus is lacking regarding the relative long‐term efficacy of radical prostatectomy (RP) versus conventional‐dose external beam radiation therapy (RT) in the treatment of patients with clinically localized prostate carcinoma. ## METHODS A
## BACKGROUND. In this article the authors report an analysis and long term results of delayedlsalvage radiation therapy administered to asymptomatic patients who had an elevated prostate specific antigen (PSA) level, many months to many years after radical prostatectomy. ## METHODS. During 198